Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2013 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
New therapeutic agents in ovarian cancer.
Curr Opin Obstet Gynecol. 2009 Feb;21(1):44-53. doi: 10.1097/GCO.0b013e32831ffe71.
Curr Opin Obstet Gynecol. 2009.
PMID: 19125003
Review.
Development of antiangiogenic agents for ovarian cancer.
Collinson FJ, Hall GD, Perren TJ, Jayson GC.
Collinson FJ, et al.
Expert Rev Anticancer Ther. 2008 Jan;8(1):21-32. doi: 10.1586/14737140.8.1.21.
Expert Rev Anticancer Ther. 2008.
PMID: 18095880
Review.
Item in Clipboard
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection.
Collinson F, Hutchinson M, Craven RA, Cairns DA, Zougman A, Wind TC, Gahir N, Messenger MP, Jackson S, Thompson D, Adusei C, Ledermann JA, Hall G, Jayson GC, Selby PJ, Banks RE.
Collinson F, et al.
Clin Cancer Res. 2013 Sep 15;19(18):5227-39. doi: 10.1158/1078-0432.CCR-13-0489. Epub 2013 Aug 9.
Clin Cancer Res. 2013.
PMID: 23935036
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite